Company profile SMMT
After 39 days of this quarter the interest is at 229.0. Based on that we can calculate that during remaining 52 days it will total up to 534.0. Summit Therapeutics -stock expected interest is significantly higher compared to previous quarter (+79.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 137 | 127 -7.3% QoQ | 169 33.1% QoQ | 132 -21.9% QoQ |
| 2020 | 172 25.5% YoY 30.3% QoQ | 152 19.7% YoY -11.6% QoQ | 145 -14.2% YoY -4.6% QoQ | 213 61.4% YoY 46.9% QoQ |
| 2021 | 136 -20.9% YoY -36.2% QoQ | 133 -12.5% YoY -2.2% QoQ | 267 84.1% YoY 100.8% QoQ | 238 11.7% YoY -10.9% QoQ |
| 2022 | 253 86.0% YoY 6.3% QoQ | 251 88.7% YoY -0.8% QoQ | 223 -16.5% YoY -11.2% QoQ | 266 11.8% YoY 19.3% QoQ |
| 2023 | 390 54.2% YoY 46.6% QoQ | 383 52.6% YoY -1.8% QoQ | 255 14.3% YoY -33.4% QoQ | 298 12.0% YoY 16.9% QoQ |
| 2024 | 229 -41.3% YoY -23.2% QoQ | - | - | - |
The average 5 years interest of Summit Therapeutics -stock was 17.51 per week. The last year interest of Summit Therapeutics -stock compared to the last 5 years has changed by 47.29%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 117.09%.
There is not enough data for Summit Therapeutics biopharmaceutical to provide analysis
There is not enough data for Summit Therapeutics biopharmaceutical to provide correlation calculation
There is not enough data for Summit Therapeutics biopharmaceutical to provide analysis
There is not enough data for Summit Therapeutics Cambridge Massachusetts to provide analysis
There is not enough data for Summit Therapeutics Cambridge Massachusetts to provide correlation calculation
There is not enough data for Summit Therapeutics Cambridge Massachusetts to provide analysis
There is not enough data for SMMT precision antibiotics to provide analysis
There is not enough data for SMMT precision antibiotics to provide correlation calculation
There is not enough data for SMMT precision antibiotics to provide analysis
There is not enough data for SMMT multidrug resistant infections to provide analysis
There is not enough data for SMMT multidrug resistant infections to provide correlation calculation
There is not enough data for SMMT multidrug resistant infections to provide analysis
There is not enough data for Summit Therapeutics pipeline to provide analysis
There is not enough data for Summit Therapeutics pipeline to provide correlation calculation
There is not enough data for Summit Therapeutics pipeline to provide analysis
Google Trends for Summit Therapeutics collaboration Akeso
Not enough data for reliable calculations!
There is not enough data for Summit Therapeutics collaboration Akeso to provide analysis
There is not enough data for Summit Therapeutics collaboration Akeso to provide correlation calculation
There is not enough data for Summit Therapeutics collaboration Akeso to provide analysis
There is not enough data for Summit Therapeutics oncology therapies to provide analysis
There is not enough data for Summit Therapeutics oncology therapies to provide correlation calculation
There is not enough data for Summit Therapeutics oncology therapies to provide analysis
There is not enough data for SMMT carbapenem-resistant Enterobacteriaceae infections to provide analysis
There is not enough data for SMMT carbapenem-resistant Enterobacteriaceae infections to provide correlation calculation
There is not enough data for SMMT carbapenem-resistant Enterobacteriaceae infections to provide analysis
There is not enough data for Summit Therapeutics headquarters Cambridge to provide analysis
There is not enough data for Summit Therapeutics headquarters Cambridge to provide correlation calculation
There is not enough data for Summit Therapeutics headquarters Cambridge to provide analysis